Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Return on Assets (2016 - 2025)

Dare Bioscience (DARE) has disclosed Return on Assets for 8 consecutive years, with 0.8% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets rose 32.0% year-over-year to 0.8%, compared with a TTM value of 0.8% through Sep 2025, up 32.0%, and an annual FY2024 reading of 1.08%, down 13.0% over the prior year.
  • Return on Assets was 0.8% for Q3 2025 at Dare Bioscience, up from 1.17% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.49% in Q3 2022 and bottomed at 5.29% in Q1 2021.
  • Average Return on Assets over 5 years is 1.48%, with a median of 1.17% recorded in 2025.
  • Peak annual rise in Return on Assets hit 508bps in 2021, while the deepest fall reached -489bps in 2021.
  • Year by year, Return on Assets stood at 0.75% in 2021, then rose by 11bps to 0.67% in 2022, then tumbled by -100bps to 1.34% in 2023, then grew by 12bps to 1.17% in 2024, then skyrocketed by 32bps to 0.8% in 2025.
  • Business Quant data shows Return on Assets for DARE at 0.8% in Q3 2025, 1.17% in Q2 2025, and 1.08% in Q1 2025.